These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21269252)

  • 1. Targeting focal adhesion kinase in neuroblastoma.
    Gillory L; Beierle EA
    Anticancer Agents Med Chem; 2010 Dec; 10(10):714-21. PubMed ID: 21269252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal adhesion kinase as a cancer therapy target.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.
    Beierle EA; Ma X; Stewart J; Nyberg C; Trujillo A; Cance WG; Golubovskaya VM
    Cell Cycle; 2010 Mar; 9(5):1005-15. PubMed ID: 20160475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the relationship between n-myc and Focal Adhesion Kinase (FAK) in neuroblastoma?
    Madonna MB
    Cell Cycle; 2010 May; 9(9):1679-80. PubMed ID: 20448460
    [No Abstract]   [Full Text] [Related]  

  • 5. FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma.
    Megison ML; Stewart JE; Nabers HC; Gillory LA; Beierle EA
    Clin Exp Metastasis; 2013 Jun; 30(5):555-68. PubMed ID: 23208732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
    Gillory LA; Stewart JE; Megison ML; Waters AM; Beierle EA
    J Surg Res; 2015 Jun; 196(2):339-49. PubMed ID: 25862488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYCN, neuroblastoma and focal adhesion kinase (FAK).
    Beierle EA
    Front Biosci (Elite Ed); 2011 Jan; 3(2):421-33. PubMed ID: 21196322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors.
    Marlowe TA; Lenzo FL; Figel SA; Grapes AT; Cance WG
    Mol Cancer Ther; 2016 Dec; 15(12):3028-3039. PubMed ID: 27638858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving therapies and FAK inhibitors for the treatment of cancer.
    Dunn KB; Heffler M; Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):722-34. PubMed ID: 21291406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of FAK in tumor metabolism and therapy.
    Zhang J; Hochwald SN
    Pharmacol Ther; 2014 May; 142(2):154-63. PubMed ID: 24333503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the MYCN effector, FAK, in neuroblastoma.
    Davidoff AM
    Cell Cycle; 2010 Mar; 9(6):1026. PubMed ID: 20410685
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
    Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting focal adhesion kinase in cancer-part I.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):713. PubMed ID: 21348852
    [No Abstract]   [Full Text] [Related]  

  • 14. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
    Zhou J; Yi Q; Tang L
    J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders.
    Yang M; Xiang H; Luo G
    Biochem Pharmacol; 2024 Jun; 224():116246. PubMed ID: 38685282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAK signaling in human cancer as a target for therapeutics.
    Lee BY; Timpson P; Horvath LG; Daly RJ
    Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of focal adhesion kinase in lung cancer.
    Dy GK
    Anticancer Agents Med Chem; 2013 May; 13(4):581-3. PubMed ID: 22934708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).
    Lu Y; Sun H
    J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of focal adhesion kinase inhibition in non-small cell lung cancer with oncogenically activated MAPK pathways.
    Zhang H; Shao H; Golubovskaya VM; Chen H; Cance W; Adjei AA; Dy GK
    Br J Cancer; 2016 Jul; 115(2):203-11. PubMed ID: 27336608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between FAK, MYCN, p53 and Mdm2 in neuroblastoma.
    Waters AM; Beierle EA
    Anticancer Agents Med Chem; 2014 Jan; 14(1):46-51. PubMed ID: 24041229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.